...
首页> 外文期刊>Chinese Medical Journal >AMPLIFICATIONS OF PROTO-ONCOGENES IN OVARIAN CARCINOMA
【24h】

AMPLIFICATIONS OF PROTO-ONCOGENES IN OVARIAN CARCINOMA

机译:卵巢癌原癌基因的扩增

获取原文
获取原文并翻译 | 示例

摘要

Thirty-two cases of ovarian carcinoma, two of normal ovaries, four of benign epithelial ovarian tumor, and three of borderline epithelial ovarian tumor were studied using Southern blot hybridization of DNA. In 15 of the 32 cases of ovarian carcinoma, peripheral lymphocytes were also studied. The amplification rate of C-myc, C-N-ras, C-Ki-ras and C-erbB-2 in ovarian carcinoma were 50%, 44%, 31% and 25% respectively. The amplification of C-Ki-ras and C-N-ras took place chiefly in cases of early stage and those of good differentiation. The amplification of C-N-ras was also found in cases of advanced stage. The amplifications of C-myc and C-erbB-2 were chiefly found in cases above stage Ⅲ and those of poor differentiation. A total of 83% of the patients who died were found to have amplifications of more than 2 proto-oncogenes, with which the amplification of C-erbB-2 was involved.
机译:使用DNA印迹杂交技术研究了32例卵巢癌,2例正常卵巢,4例良性上皮性卵巢肿瘤和3例临界上皮性卵巢肿瘤。在32例卵巢癌病例中的15例中,还研究了外周淋巴细胞。 C-myc,C-N-ras,C-Ki-ras和C-erbB-2在卵巢癌中的扩增率分别为50%,44%,31%和25%。 C-Ki-ras和C-N-ras的扩增主要发生在早期和分化良好的病例中。在晚期病例中也发现了C-N-ras的扩增。 C-myc和C-erbB-2的扩增主要在Ⅲ期以上及分化较差的病例中发现。总共有83%的死亡患者被发现扩增了2种以上的原癌基因,其中涉及C-erbB-2的扩增。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号